🔴 Hims & Hers Health is trading 4% down today with no clear company-specific catalyst

Hims & Hers Health is trading 4.07% down at €25.90, with no clear company-specific catalyst explaining the August 6, 2026 decline.

• The company announced a new AI-native Hers app and smart scale for weight-loss members, a positive operational update, not an obvious bearish trigger.
• Investors may be weighing the FTC lawsuit announced July 29 and positioning ahead of the August 10 second-quarter earnings report.
• Healthcare is rising 1.31%; major U.S. indexes are mixed to lower, providing no clear market explanation.